A detailed history of Marshall Wace, LLP transactions in Boston Scientific Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 8,240,519 shares of BSX stock, worth $750 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
8,240,519
Previous 6,720,480 22.62%
Holding current value
$750 Million
Previous $518 Million 33.43%
% of portfolio
0.89%
Previous 0.72%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $111 Million - $128 Million
1,520,039 Added 22.62%
8,240,519 $691 Million
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $243 Million - $280 Million
3,608,158 Added 115.93%
6,720,480 $518 Million
Q1 2024

May 15, 2024

BUY
$57.6 - $68.62 $86.1 Million - $103 Million
1,495,021 Added 92.44%
3,112,322 $213 Million
Q4 2023

Feb 14, 2024

SELL
$48.64 - $57.81 $106 Million - $126 Million
-2,185,557 Reduced 57.47%
1,617,301 $93.5 Million
Q3 2023

Nov 14, 2023

BUY
$50.19 - $54.68 $96.4 Million - $105 Million
1,921,591 Added 102.14%
3,802,858 $201 Million
Q2 2023

Aug 14, 2023

SELL
$49.72 - $54.64 $117 Million - $128 Million
-2,351,499 Reduced 55.55%
1,881,267 $102 Million
Q1 2023

May 15, 2023

SELL
$45.09 - $50.03 $71.7 Million - $79.5 Million
-1,589,247 Reduced 27.3%
4,232,766 $212 Million
Q4 2022

Feb 14, 2023

SELL
$39.56 - $47.22 $169 Million - $202 Million
-4,268,346 Reduced 42.3%
5,822,013 $269 Million
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $14.3 Million - $42.6 Million
-388,778 Reduced 3.71%
10,090,359 $391 Million
Q2 2022

Aug 15, 2022

BUY
$35.24 - $47.1 $33.1 Million - $44.2 Million
938,755 Added 9.84%
10,479,137 $391 Million
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $130 Million - $144 Million
3,182,702 Added 50.06%
9,540,382 $423 Million
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $206 Million - $243 Million
5,411,822 Added 572.16%
6,357,680 $270 Million
Q3 2021

Nov 15, 2021

SELL
$41.23 - $45.88 $1.19 Million - $1.33 Million
-28,943 Reduced 2.97%
945,858 $41 Million
Q2 2021

Aug 13, 2021

BUY
$38.58 - $44.24 $21.8 Million - $25 Million
565,427 Added 138.12%
974,801 $41.7 Million
Q1 2021

May 17, 2021

SELL
$35.27 - $39.67 $11.5 Million - $12.9 Million
-325,708 Reduced 44.31%
409,374 $15.8 Million
Q4 2020

Feb 16, 2021

BUY
$33.15 - $41.97 $8.41 Million - $10.7 Million
253,798 Added 52.73%
735,082 $26.4 Million
Q3 2020

Nov 16, 2020

SELL
$34.44 - $42.23 $129 Million - $159 Million
-3,759,644 Reduced 88.65%
481,284 $18.4 Million
Q2 2020

Aug 13, 2020

BUY
$30.19 - $39.11 $15.3 Million - $19.8 Million
506,108 Added 13.55%
4,240,928 $149 Million
Q1 2020

May 15, 2020

SELL
$25.83 - $45.71 $115 Million - $203 Million
-4,436,532 Reduced 54.29%
3,734,820 $122 Million
Q4 2019

Feb 14, 2020

SELL
$37.87 - $45.37 $11.1 Million - $13.3 Million
-292,339 Reduced 3.45%
8,171,352 $370 Million
Q3 2019

Nov 14, 2019

SELL
$40.31 - $43.45 $43.6 Million - $47 Million
-1,081,691 Reduced 11.33%
8,463,691 $344 Million
Q2 2019

Aug 14, 2019

BUY
$34.91 - $42.98 $179 Million - $221 Million
5,131,591 Added 116.26%
9,545,382 $410 Million
Q1 2019

May 14, 2019

BUY
$32.91 - $40.75 $104 Million - $129 Million
3,158,088 Added 251.5%
4,413,791 $169 Million
Q4 2018

Feb 14, 2019

BUY
$31.73 - $39.04 $19.1 Million - $23.5 Million
602,875 Added 92.35%
1,255,703 $44.4 Million
Q3 2018

Nov 14, 2018

SELL
$32.83 - $38.63 $40.1 Million - $47.1 Million
-1,220,533 Reduced 65.15%
652,828 $25.1 Million
Q2 2018

Aug 14, 2018

BUY
$26.84 - $34.32 $47 Million - $60.1 Million
1,751,500 Added 1437.29%
1,873,361 $61.3 Million
Q1 2018

May 15, 2018

BUY
$25.2 - $28.54 $273,495 - $309,744
10,853 Added 9.78%
121,861 $3.33 Million
Q4 2017

Feb 14, 2018

BUY
$24.79 - $29.8 $744,989 - $895,549
30,052 Added 37.12%
111,008 $2.75 Million
Q3 2017

Nov 13, 2017

BUY
$26.26 - $29.17 $2.13 Million - $2.36 Million
80,956
80,956 $2.35 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.